Urology · Los Angeles, CA
NPI
1790957504
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
8631 W 3rd St, Suite 715e
Los Angeles, CA, 90048
Phone (310) 278-8330
Groups this clinician bills Medicare through
Medicare paid, 2024
$433K
25,886 services
Medicare patients, 2024
874
Average age 78
Drug cost, 2024
$566K
2,382 prescriptions
Company payments, 2025
$1,217
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susan L Rusnack was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,501 times for 57 patients. In total Susan L Rusnack billed 25,886 services in 125 codes, and Medicare paid $433K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,501 | 57 | $4.84 | $70K |
| 81000 Clinical Chemistry | Office | 1,548 | 755 | $3.94 | $6,094 |
| 82570 Clinical Chemistry | Office | 1,546 | 754 | $5.08 | $7,847 |
| 99213 Office E&M - Established | Office | 1,095 | 590 | $65.27 | $71K |
| 87077 Bacterial Culture | Office | 873 | 325 | $7.91 | $6,905 |
| 87086 Bacterial Culture | Office | 686 | 354 | $7.90 | $5,422 |
| 87184 General Laboratory | Office | 476 | 231 | $7.33 | $3,489 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 459 | 370 | $37.18 | $17K |
| 64566 Musculoskeletal | Office | 347 | 42 | $90.31 | $31K |
| 95971 Electrical Nerve Conductivity | Office | 347 | 42 | $35.59 | $12K |
| 99211 Office E&M - Established | Office | 263 | 129 | $17.48 | $4,598 |
| 99204 Office E&M - New | Office | 228 | 228 | $114.46 | $26K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 206 | 180 | $46.68 | $9,616 |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 205 | 30 | $1.90 | $389 |
| 87147 Immunoassay | Office | 171 | 128 | $5.06 | $866 |
By year: 2022 $665K for 31,114 services; 2023 $554K for 27,383 services; 2024 $433K for 25,886 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 1,548 | 755 | $3.94 | $6,094 |
| 82570 Clinical Chemistry | 1,546 | 754 | $5.08 | $7,847 |
| 87077 Bacterial Culture | 873 | 325 | $7.91 | $6,905 |
| 87086 Bacterial Culture | 686 | 354 | $7.90 | $5,422 |
| 87184 General Laboratory | 476 | 231 | $7.33 | $3,489 |
| 87147 Immunoassay | 171 | 128 | $5.06 | $866 |
| 80069 Clinical Chemistry | 51 | 43 | $8.51 | $434 |
| 36415 Venipuncture Blood Collection | 50 | 43 | $8.65 | $433 |
| 85025 Blood Count | 37 | 30 | $7.61 | $282 |
| 80076 Clinical Chemistry | 34 | 28 | $8.01 | $272 |
Medicare prescription drug claims, 2024
In 2024, the drug Susan L Rusnack prescribed most often to Medicare patients was Gemtesa (Vibegron), with 415 prescriptions and refills. In total Susan L Rusnack wrote 2,382 Medicare prescriptions that cost $566K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 415 | 574 | 83 | $274K |
| Estradiol Generic | 354 | 842 | 189 | $26K |
| Myrbetriq Mirabegron | 231 | 340 | 58 | $153K |
| Cephalexin Generic | 193 | 235 | 97 | $1,176 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 166 | 182 | 87 | $2,593 |
| Methenamine Hippurate Generic | 108 | 162 | 42 | $5,555 |
| Imvexxy Estradiol | 98 | 112 | 19 | $26K |
| Tamsulosin Hcl Generic | 62 | 120 | 22 | $588 |
| Cefuroxime Cefuroxime Axetil | 60 | 60 | 43 | $624 |
| Estring Estradiol | 54 | 161 | 18 | $29K |
| Ciprofloxacin Hcl Generic | 53 | 53 | 44 | $265 |
| Trospium Chloride Generic | 50 | 68 | 19 | $1,068 |
| Finasteride Generic | 49 | 87 | Under 11 | $403 |
| Solifenacin Succinate Generic | 44 | 95 | 17 | $2,425 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 40 | 51 | 31 | $140 |
Brand drugs: 893 claims; generic drugs: 1,489 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susan L Rusnack $1,217 ($1,217 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $196.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $196 |
| Bluewind Medical | 2 | $169 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $146 |
| Astellas Pharma US Inc 4503.T | 2 | $130 |
| Telix Pharmaceuticals TLX | 3 | $100 |
| Ferring Pharmaceuticals Inc. | 5 | $96.25 |
| Janssen Biotech, Inc. JNJ | 4 | $93.65 |
| Calyxo, Inc. | 1 | $55.19 |
| Medtronic, Inc. MDT | 1 | $53.85 |
| Immunitybio, Inc. IBRX | 2 | $46.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.